Controlled Sedation for Cataract Surgery

• Status: Terminated
• Trial end date: 2016-01-30
• Target enrollment: 0
• Participant gender: All

Summary

This study evaluates the surgeon and patient´s satisfaction who undergoes cataract surgery using either dexmedetomidine or remifentanil as sedation

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Fundación Universitaria de Ciencias de la Salud
• Treatments: Dexmedetomidine; Remifentanil

Criteria

Inclusion Criteria:

• subject has cataract,

• subject older than 18 years,

• local anesthesia and sedation.

Exclusion Criteria:

• general anesthesia,

• history of consumption of sedatives.